Delivering Innovative Therapeutic Options for Gastrointestinal Diseases and Women’s Health

Sebela Pharmaceuticals® is a U.S. pharmaceutical
company with a market-leading position in Gastroenterology
and a focus on innovation in Women's Health.

MISSION, VISION AND VALUES >

Sebela Pharmaceuticals Announces New Division Named Sebela Women's Health

READ THE PRESS RELEASE >

Sebela Pharmaceuticals Appoints Victor Parker as Chief Commercial Officer

READ THE PRESS RELEASE >

Sebela Pharmaceuticals Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada.

READ THE PRESS RELEASE >
MORE NEWS AND EVENTS >
RESEARCH AND DEVELOPMENT

RESEARCH AND DEVELOPMENT

Sebela Pharmaceuticals’ development strategy aims to advance the company’s mission of improving patients’ lives with innovative pharmaceuticals. Through our affiliate Braintree, Sebela is leading the way in Gastroenterology.

LEARN MORE >

DISCOVER SEBELA WOMEN’S HEALTH

Sebela Women’s Health seeks to enrich the health and well-being of women – and the lives of those who care about them. We're developing next-generation therapeutics with innovative features that help address the needs of women today.

DISCOVER MORE ABOUT US >
DISCOVER SEBELA WOMEN'S HEALTH